GE HealthCare Technologies (NASDAQ:GEHC) Raised to "Buy" at Wall Street Zen

Key Points

• Wall Street Zen upgraded GE HealthCare Technologies from “hold” to “buy.” Overall analyst sentiment is “Moderate Buy,” with 12 Buy ratings, 11 Holds, and a consensus price target of $80.57.
• GE HealthCare beat quarterly expectations, reporting adjusted EPS of $1.34 versus the $1.20 consensus and revenue of $5.51 billion versus $5.35 billion. Revenue rose 7.2% year over year.
• Management raised its full-year outlook to approximately 4% organic revenue growth, adjusted EPS of $4.95–$5.05, and at least $1.6 billion in free cash flow; institutional investors own 82.06% of the stock.

GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) was upgraded by analysts at Wall Street Zen from a "hold" rating to a "buy" rating in a research note issued on Saturday, Wall Street Zen reports.

Several other analysts also recently issued reports on GEHC. BTIG Research boosted their target price on shares of GE HealthCare Technologies from $75.00 to $83.00 and gave the company a "buy" rating in a research note on Wednesday. Weiss Ratings raised GE HealthCare Technologies from a "hold (c-)" rating to a "hold (c)" rating in a research report on Tuesday, October 6th. Needham & Company LLC reiterated a "buy" rating and set a $93.00 price target on shares of GE HealthCare Technologies in a report on Monday, October 5th. Bank of America reissued a "neutral" rating on shares of GE HealthCare Technologies in a research report on Thursday. Finally, Hovde Group assumed coverage on GE HealthCare Technologies in a research note on Friday, July 17th. They issued a "market perform" rating and a $14.00 price objective for the company. Twelve analysts have rated the stock with a Buy rating and eleven have given a Hold rating to the stock. Based on data from MarketBeat, GE HealthCare Technologies has a consensus rating of "Moderate Buy" and a consensus price target of $80.57.

GE HealthCare Technologies Stock Up 0.2%

GEHC stock opened at $76.57 on Friday. GE HealthCare Technologies has a 52-week low of $58.75 and a 52-week high of $89.77. The company's 50 day simple moving average is $68.45 and its 200-day simple moving average is $70.06. The company has a debt-to-equity ratio of 0.86, a current ratio of 1.30 and a quick ratio of 0.97. The firm has a market capitalization of $34.62 billion, a P/E ratio of 16.15, a P/E/G ratio of 1.99 and a beta of 0.73.

GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last issued its quarterly earnings results on Wednesday, October 28th. The company reported $1.34 EPS for the quarter, beating the consensus estimate of $1.20 by $0.14. GE HealthCare Technologies had a net margin of 9.96% and a return on equity of 20.45%. The business had revenue of $5.51 billion during the quarter, compared to the consensus estimate of $5.35 billion. During the same quarter in the prior year, the firm earned $1.07 EPS. The firm's quarterly revenue was up 7.2% on a year-over-year basis. As a group, equities research analysts anticipate that GE HealthCare Technologies will post 5.01 EPS for the current year.

Institutional Investors Weigh In On GE HealthCare Technologies

Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Mount Vernon Associates Inc. MD lifted its position in GE HealthCare Technologies by 0.8% during the 1st quarter. Mount Vernon Associates Inc. MD now owns 18,165 shares of the company's stock worth $1,293,000 after buying an additional 144 shares in the last quarter. Carnegie Investment Counsel boosted its stake in shares of GE HealthCare Technologies by 2.0% during the 3rd quarter. Carnegie Investment Counsel now owns 7,678 shares of the company's stock worth $502,000 after buying an additional 151 shares during the last quarter. Essex Financial Services Inc. boosted its stake in shares of GE HealthCare Technologies by 1.8% during the 1st quarter. Essex Financial Services Inc. now owns 9,024 shares of the company's stock worth $642,000 after buying an additional 156 shares during the last quarter. Beacon Financial Advisory LLC boosted its stake in shares of GE HealthCare Technologies by 5.8% during the 1st quarter. Beacon Financial Advisory LLC now owns 2,965 shares of the company's stock worth $211,000 after buying an additional 162 shares during the last quarter. Finally, Physician Wealth Advisors Inc. grew its holdings in shares of GE HealthCare Technologies by 60.4% in the 1st quarter. Physician Wealth Advisors Inc. now owns 433 shares of the company's stock valued at $31,000 after acquiring an additional 163 shares in the last quarter. Hedge funds and other institutional investors own 82.06% of the company's stock.

Key GE HealthCare Technologies News

Here are the key news stories impacting GE HealthCare Technologies this week:

• Positive Sentiment: Strong Q3 results beat expectations. GE HealthCare reported $5.51 billion in revenue, above the $5.35 billion consensus estimate, while EPS of $1.34 exceeded expectations of $1.20. Revenue increased 7.2% year over year, helping drive the post-earnings gap higher. GE HealthCare Technologies Shares Gap Up After Strong Earnings
• Positive Sentiment: Management raised its full-year outlook. The company now expects approximately 4% organic revenue growth, adjusted EPS of $4.95–$5.05, and at least $1.6 billion in free cash flow. Organic growth of 6.2% and margin expansion in the quarter further strengthened the bullish case. GE HealthCare: Broad-Based Growth Makes The Bull Case More Compelling
• Positive Sentiment: Analysts raised valuation targets. RBC increased its target from $80 to $90 and maintained an “outperform” rating. BNP Paribas lifted its target from $96 to $100, while Mizuho raised its target from $85 to $90. BTIG Research also forecast substantial potential appreciation. BNP Paribas Price Target Update
• Neutral Sentiment: JPMorgan raised its price target from $70 to $80 but kept a “neutral” rating, suggesting recognition of the earnings improvement while retaining a cautious stance on valuation. JPMorgan GE HealthCare Rating
• Neutral Sentiment: A value comparison with Haemonetics highlights GEHC’s investment appeal but does not introduce a material new catalyst for the stock. GEHC Versus HAE Value Comparison

About GE HealthCare Technologies

GE HealthCare Technologies Inc is a global medical technology company that develops and provides products, services and digital solutions for healthcare providers. Its offerings are designed to support the diagnosis, treatment and monitoring of patients across hospitals, outpatient facilities, imaging centers and other care settings.

The company's portfolio includes medical imaging systems such as computed tomography, magnetic resonance imaging, molecular imaging, surgical imaging and X-ray equipment.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.